Market icon

Which vaccines will RFK end recommendations for?

$1,281,380 Vol.

OUTCOME

% CHANCE

Rules

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

Volume

$1,281,380

End Date

Dec 31, 2025

shield

Beware of external links.

$1,281,380 Vol.

Market icon

Which vaccines will RFK end recommendations for?

OUTCOME

% CHANCE

Measles Mumps and Rubella

$257,955 Vol.

6%

HPV

$304,852 Vol.

4%

COVID-19

$561,051 Vol.

3%

Hepatitis B

$123,596 Vol.

3%

Influenza

$21,752 Vol.

3%

Polio

$12,174 Vol.

2%

About

Volume

$1,281,380

End Date

Dec 31, 2025